back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-28 20:49 Tx date 2024-03-28 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
$8,637
+2,879 vol $3.00 each |
2,879 | |
| Filed 2024-03-28 20:43 Tx date 2021-09-09 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-28 20:42 Tx date 2024-03-28 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$13,531
+5,758 vol $2.35 each |
5,758 | |
| Filed 2024-03-28 20:41 Tx date 2021-09-09 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-01-15 15:18 Tx date 2024-01-08 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,977
+2,000 vol $1.99 each |
2,000 | |
| Filed 2024-01-08 13:59 Tx date 2024-01-08 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,977
+2,000 vol $1.99 each |
||
| Filed 2024-01-08 13:59 Tx date 2024-01-08 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,977
+2,000 vol $1.99 each |
2,000 | |
| Filed 2024-01-08 13:56 Tx date 2021-09-09 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-05-24 11:53 Tx date 2023-05-23 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,500
+50,000 vol $1.61 each |
225,000 | |
| Filed 2023-02-24 21:42 Tx date 2023-02-22 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$48,500
+25,000 vol $1.94 each |
175,000 | |
| Filed 2022-11-17 17:04 Tx date 2022-11-15 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$87,000
+50,000 vol $1.74 each |
150,000 | |
| Filed 2022-04-18 12:44 Tx date 2022-04-12 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$110,000
+50,000 vol $2.20 each |
100,000 | |
| Filed 2021-09-16 16:09 Tx date 2021-09-13 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+50,000 vol $2.10 each |
50,000 | |
| Filed 2021-09-16 16:08 Tx date 2021-09-09 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-16 16:07 Tx date 2021-09-09 |
$NGEN
NervGen Pharma Corp. |
McKerracher, Krista
4 - Director of Issuer
Holder: Fig Advisory LLC (Indirect Ownership)
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 |